- Home
- MDBH vs ECOR Comparison
MDBH vs ECOR Comparison
Compare MDBH & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDBH
- ECOR
- Stock Information
- Founded
- MDBH 1997
- ECOR 2005
- Country
- MDBH United States
- ECOR United States
- Employees
- MDBH N/A
- ECOR N/A
- Industry
- MDBH
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- MDBH
- ECOR Health Care
- Exchange
- MDBH Nasdaq
- ECOR Nasdaq
- Market Cap
- MDBH 35.1M
- ECOR 39.6M
- IPO Year
- MDBH 2023
- ECOR 2018
- Fundamental
- Price
- MDBH $3.32
- ECOR $5.86
- Analyst Decision
- MDBH
- ECOR Strong Buy
- Analyst Count
- MDBH 0
- ECOR 2
- Target Price
- MDBH N/A
- ECOR $25.50
- AVG Volume (30 Days)
- MDBH 24.2K
- ECOR 69.6K
- Earning Date
- MDBH 11-14-2025
- ECOR 11-05-2025
- Dividend Yield
- MDBH N/A
- ECOR N/A
- EPS Growth
- MDBH N/A
- ECOR N/A
- EPS
- MDBH 0.56
- ECOR N/A
- Revenue
- MDBH N/A
- ECOR $29,835,000.00
- Revenue This Year
- MDBH N/A
- ECOR $24.55
- Revenue Next Year
- MDBH N/A
- ECOR $41.13
- P/E Ratio
- MDBH $5.87
- ECOR N/A
- Revenue Growth
- MDBH N/A
- ECOR 27.90
- 52 Week Low
- MDBH $3.16
- ECOR $4.16
- 52 Week High
- MDBH $9.42
- ECOR $19.49
- Technical
- Relative Strength Index (RSI)
- MDBH 37.07
- ECOR 65.83
- Support Level
- MDBH $3.41
- ECOR $4.47
- Resistance Level
- MDBH $4.80
- ECOR $5.17
- Average True Range (ATR)
- MDBH 0.33
- ECOR 0.33
- MACD
- MDBH -0.10
- ECOR 0.10
- Stochastic Oscillator
- MDBH 1.28
- ECOR 78.21
About MDBH MDB Capital Holdings LLC common
MDB Capital Holdings LLC is an investment holding company that operates through its subsidiaries and focuses on early-stage technology companies through public offerings. The company's purpose is to engage with companies holding visionary technology, inventors, and technology entrepreneurs. The Company operates in two reportable segments: a broker dealer & intellectual property service, and the technology development segment. The broker dealer & intellectual property service segment, which derives key revenue, is engaged in conducting private and public securities offerings and offers in-depth patent research used for investment banking due diligence.
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.